Cite Filings / XFOR / 0001193125-19-069282
Feed Companies Filings Check
Sign in
425

Prospectus/Communication re Business Combination

X4 Pharmaceuticals, Inc · Filed 2019-03-08 · Acc 0001193125-19-069282

Documents 1

  • 425 Prospectus/Communication re Business Combination , d721507d8k.htm

Around this filing

  • 2019-03-13 8-K Acquisition or sale completed · New debt or obligation · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Other events
  • 2019-03-11 10-K Annual Report
  • 2019-03-11 S-8 Securities Offered to Employees in Benefit Plans
  • 2019-03-08 DEFA14A Proxy Materials
  • 2019-03-08 425 Prospectus/Communication re Business Combination
  • 2019-03-08 8-K Material agreement
  • 2019-03-01 425 Prospectus/Communication re Business Combination

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d721507d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…